Trump Admin Inches Closer to Unprecedented Drug Price Transparency Requirements
-
May 30, 2025
The Trump administration on May 22 revealed multiple initiatives to improve health care price transparency, including updating guidance for health plans to publish data and seeking public input via requests for information (RFIs). Kolton Gustafson, an Avalere Health principal, tells AIS Health the announcements are “very significant for both plans and pharmaceutical manufacturers,” although he notes it is still to be determined whether they will lead to lower prices for health care services and prescription medications.
The administration said the moves by HHS, along with the Labor and Treasury departments, will strengthen the Transparency in Coverage (TiC) rule, which was finalized in November 2020 and required health insurance companies to publicly post in-network rates, out-of-network allowed amounts and other data, as well as the Hospital Price Transparency rule, which was finalized in November 2019 and required hospitals to publicly disclose gross charges, cash prices, negotiated rates and other information.
Read more
© 2025 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.